Report post
Agenus CEO Garo Armen spotlights multibillion-dollar opportunities in biotech, highlighting the company's novel cancer treatment with BOT/BAL. With Agenus (AGEN) trading at $.79 cents, billionaire Steve Cohen's recent investment adds credibility. Explore the potential of Agenus stock for lucrative returns.

Related articles

The World's Leading Crypto Trading Platform

Get my welcome gifts